A Randomized, Controlled Study of Repeat Dose Sustained Release Lidocaine for Treatment of Chronic Scrotal Pain

Recruiting

Phase 2

LidocaineA Randomized, Controlled Study of Repeat Dose Sustained Release Lidocaine for Treatment of Chronic Scrotal Pain

Sponsor:

Sustained Therapeutics Inc.

Code:

NCT05707208

Conditions

Chronic Pain

Eligibility Criteria

Sex: Male

Age: 19+

Healthy Volunteers: Not accepted

Interventions

ST-01

1% Lidocaine HCL

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-04. This information was provided to ClinicalTrials.gov by Sustained Therapeutics Inc. on 2025-05-16.